2.10 Stable angina, acute coronary syndromes, and fibrinolysis

Contents

• 2.1 Positive inotropic drugs
  • 2.1.1 Cardiac glycosides
• 2.2 Diuretics
  • 2.2.1 Thiazides and related diuretics
  • 2.2.2 Loop diuretics
  • 2.2.3 Potassium-sparing diuretics and aldosterone antagonists
  • 2.2.4 Potassium-sparing diuretics with other diuretics
• 2.3 Anti-arrhythmic drugs
  • 2.3.2 Drugs for arrhythmias
• 2.4 Beta-adrenoceptor blocking drugs
• 2.5 Hypertension and heart failure
  • 2.5.2 Centrally acting antihypertensive drugs
  • 2.5.4 Alpha-adrenoceptor blocking drugs
  • 2.5.5 Drugs affecting the renin-angiotensin system
    • 2.5.5.1 Angiotensin-converting enzyme inhibitors
    • 2.5.5.2 Angiotensin-II receptor antagonists (AIIRAs/ARBs)
    • 2.5.5.3 Renin inhibitors
• 2.6 Nitrates, calcium-channel blockers and other antianginal drugs
  • 2.6.1 Nitrates
  • 2.6.2 Calcium-channel blockers (CCBs)
  • 2.6.3 Other antianginal drugs
  • 2.6.4 Peripheral vasodilators and related drugs
• 2.7 Sympathomimetics
• 2.8 Anticoagulants and protamine
  • 2.8.1 Parenteral anticoagulants
  • 2.8.2 Oral anticoagulants
    • 2.8.2.1 Atrial fibrillation
    • 2.8.2.2 Prophylaxis of venous thromboembolism in orthopaedics-specialist use in secondary care only
    • 2.8.2.3 Treatment of pulmonary embolism and deep vein thrombosis and prevention of recurrent
    • 2.8.2.4 Acute coronary syndrome
• 2.9 Antiplatelet drugs
• 2.10 Stable angina, acute coronary syndromes, and fibrinolysis
• 2.11 Antifibrinolytic drugs and haemostatics
• 2.12 Lipid-regulating drugs